JP2006003293A - Method for measuring ability to inhibit carcinoma metastasis and measuring instrument thereof - Google Patents

Method for measuring ability to inhibit carcinoma metastasis and measuring instrument thereof Download PDF

Info

Publication number
JP2006003293A
JP2006003293A JP2004182162A JP2004182162A JP2006003293A JP 2006003293 A JP2006003293 A JP 2006003293A JP 2004182162 A JP2004182162 A JP 2004182162A JP 2004182162 A JP2004182162 A JP 2004182162A JP 2006003293 A JP2006003293 A JP 2006003293A
Authority
JP
Japan
Prior art keywords
cells
measuring
endothelial cells
vascular endothelial
metastasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004182162A
Other languages
Japanese (ja)
Other versions
JP4587281B2 (en
Inventor
Norio Nagao
則男 長尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2004182162A priority Critical patent/JP4587281B2/en
Publication of JP2006003293A publication Critical patent/JP2006003293A/en
Application granted granted Critical
Publication of JP4587281B2 publication Critical patent/JP4587281B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for measuring and retrieving ingredients, having the ability to inhibit carcinoma metastasis and measuring the degree of their metastasis inhibition, in a carcinoma metastasis model system reflecting in-vivo kinetics in an initial phase-surrounding carcinoma cells and vascular endothelial cells from a view point on the side of host cells for the purpose of screening drugs having a metastasis inhibiting action for prognostic improvements, regarding patients who have experienced carcinoma detection and extirpative surgery, and to provide a measuring instrument. <P>SOLUTION: In this method, to coexistently culture both the vascular endothelial cells (5) and the carcinoma cells without direct contact, supply ingredients involved in a cleavage degree part (9) of the vascular endothelial cells considered as secreting from carcinoma cells, and measure the degree of its cleavage by measuring the electrical resistance level between an upper layer part (7) and a lower layer part (8) of a culture compartment. The carcinoma metastasis inhibition ability measuring instrument uses this measuring method. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

この発明は、癌転移抑制能を有する成分検索(スクリーニング)し、抑制能測定する方法および測定器に関するものである。   The present invention relates to a method and a measuring instrument for searching (screening) a component having cancer metastasis inhibiting ability and measuring the inhibiting ability.

従来、一般に広く行われている癌転移抑制作用に対する被検試薬スクリーニングは、マウスを用いた動物実験で行われている。(非特許文献1)
特開平5−211893号公報
Conventionally, screening of test reagents for cancer metastasis inhibitory action, which is generally performed widely, has been performed by animal experiments using mice. (Non-Patent Document 1)
Japanese Patent Laid-Open No. 5-21893

また、試験管内での転移抑制剤の効果判定法としては、浸潤、運動、血管新生の転移形成の各ステップに則した評価法が考案されて広く普及している。(非特許文献1)
がん転移研究会編『がんの浸潤・転移研究マニアル』 金芳堂 1994年
Moreover, as a method for determining the effect of a metastasis inhibitor in a test tube, an evaluation method in accordance with each step of invasion, exercise, and metastasis formation of angiogenesis has been devised and widely used. (Non-Patent Document 1)
Cancer Metastasis Study Group “Cancer Invasion and Metastasis Research Manual” Kinyoshido 1994

しかし、実験動物に癌細胞を投与し、転移形成臓器に転移した結節数を計測する動物実験では、転移巣形成までに3〜4週間を要し、不便である。うさぎの角膜を用いる血管新生能の測定法も含めて、大量のサンプルを処理する必要がある被検試薬を一次スクリーニングに動物を大量に扱うことは動物愛護の精神からも安易に行うことは許されない。   However, in animal experiments in which cancer cells are administered to experimental animals and the number of nodules metastasized to metastasis-forming organs is measured, it takes 3 to 4 weeks to form metastases, which is inconvenient. Including the method of measuring angiogenesis using a rabbit cornea, it is permissible to handle a large amount of test reagents that need to process a large amount of samples for primary screening from the viewpoint of animal welfare. Not.

従って、上記の公知技術が示すように、実験動物を用いることなく、試験管内で宿主細胞への影響を迅速、的確に癌移転の動態を把握することが出来る測定方法の確立が望まれている。   Therefore, as shown in the above known technique, it is desired to establish a measurement method capable of quickly and accurately grasping the kinetics of cancer transfer in a test tube without using an experimental animal. .

さらに、浸潤能を測定する方法として代表的なものに、ケモタキシスチャンバーに取り付けたフィルター上に細胞外マトリックス成分を塗布し、さらに、その上に内皮細胞を飽和状態になるまで培養し、その上に癌細胞を一定時間、重層培養して、内皮細胞間隔とフィルターの細孔とを貫通して下のウエルに落下する癌細胞の数を計測することで癌細胞の浸潤能を測定するものがある。(例えば、特許文献1)
さらに、特許文献1に記載された方法は、癌細胞の観点から癌細胞の内皮細胞への浸潤能、運動能を評価する系である。
Furthermore, as a typical method for measuring the infiltration ability, an extracellular matrix component is applied on a filter attached to a chemotaxis chamber, and further, endothelial cells are cultured on the filter until saturation, The cancer cells are cultivated in layers for a certain period of time, and the invasion capacity of the cancer cells is measured by counting the number of cancer cells that pass through the endothelial cell interval and the filter pores and fall into the lower well. There is. (For example, Patent Document 1)
Furthermore, the method described in Patent Document 1 is a system for evaluating the ability of cancer cells to infiltrate endothelial cells and motility from the viewpoint of cancer cells.

しかしながら、先行する,これら特許技術では、癌細胞と宿主側に相当する正常細胞の内皮細胞とが、直接、接触するために、臨床上の癌細胞を取り除く体内動態の観点から見ると、癌転移ステップである、
1) 癌細胞の原発巣での増殖
2) 周辺組織への浸潤、
3) 血管内への侵入
4) 血管内移動
5) 転移臓器血管への定着
6) 血管外脱出を経て、
転移臓器組織で増殖し、転移巣形成に至るステップにおいて、血管内への侵入に相当し、病期は進行した段階であり、転移抑制、転移予防が手遅れとなステージとなる。
However, according to these patented technologies, cancer metastasis from the viewpoint of pharmacokinetics in which cancer cells are removed clinically because the cancer cells and the endothelial cells of normal cells corresponding to the host are in direct contact with each other. Is a step,
1) Proliferation of cancer cells at the primary lesion 2) Infiltration of surrounding tissues,
3) Invasion into blood vessels 4) Intravascular movement 5) Establishment of metastatic organs in blood vessels 6) After evacuation
In the step of proliferating in metastasis organ tissue and reaching metastasis formation, it corresponds to invasion into blood vessels, and the stage is advanced, and metastasis suppression and metastasis prevention are too late and become a stage.

また、内皮細胞の開裂レベルを共焦点レーザー顕微鏡によって形態が変化した内皮細胞を計測することで評価する系が報告されている。(非特許文献2)
International Journal of Oncology 21:541-546 2002
In addition, a system has been reported in which the level of endothelial cell cleavage is evaluated by measuring endothelial cells whose morphology has been changed by a confocal laser microscope. (Non-Patent Document 2)
International Journal of Oncology 21: 541-546 2002

しかしながら、共焦点レーザー顕微鏡という高価な顕微鏡を必要とする上に、上述した従来の顕微鏡下が細胞数を計測する系では細胞の見極めに測定者による人為的要因が入り込む可能性が拭いきれず問題であった。   However, in addition to the need for an expensive microscope called a confocal laser microscope, the above-mentioned conventional system that measures the number of cells under the microscope does not completely eliminate the possibility that an artificial factor may be introduced by the measurer to determine the cells. Met.

そこで、この発明は、内皮細胞の開裂状況の僅かな変化も検出可能にした感受性に優れ、長時間測定にも対応でき、実施者の個人差が入り込まない、簡便な操作による測定手順を提供し、また、癌が発見され、摘出手術を受けた後の患者を念頭におき、その予後改善を目指す転移抑制作用を有する薬剤をスクリーニングする目的で、宿主細胞側の観点から癌細胞と血管内皮細胞とを取り巻く初期段階の生体内動態を反映した癌転移モデル系である癌転移抑制能を有する成分を検索し、その転移抑制過程を測定する方法および測定器を提供・開発することにある。   Therefore, the present invention provides a measurement procedure by a simple operation that is excellent in sensitivity that can detect even a slight change in the cleavage state of endothelial cells, can be used for long-time measurement, and does not enter the individual differences of the practitioner. In addition, cancer cells and vascular endothelial cells from the viewpoint of host cells are used for the purpose of screening for drugs that have metastasis-suppressing effects aimed at improving the prognosis of patients after cancer is found and undergoes resection surgery. To provide a component and a method for measuring a metastasis suppression process by searching for a component having cancer metastasis suppression ability, which is a cancer metastasis model system reflecting the in vivo dynamics in the early stage surrounding the above.

以上の課題を解決するために、第一の発明は、癌転移能測定法、即ち,方法の発明であり、抗転移剤の候補となる物質を宿主側の内皮細胞の観点から選別することを目的として血管内皮細胞と癌細胞を共存培養することで生ずる血管内皮細胞の細胞間隔程度を内皮細胞を横切る電気的抵抗量で評価する方法である。   In order to solve the above-mentioned problems, the first invention is a method for measuring cancer metastasis, that is, a method invention, wherein a substance that is a candidate for an antimetastatic agent is selected from the viewpoint of host endothelial cells. The objective is to evaluate the degree of cell spacing between vascular endothelial cells produced by co-culturing vascular endothelial cells and cancer cells by the amount of electrical resistance across the endothelial cells.

また、第二の発明は、抵抗測定器の発明であり、化学走性を解析するために考案された既存の装置を用いて、ケモタキシスチャンバーである細孔を有するポリカーボネートフィルターとポリスチレン製筒状の壁からなる小区画を用いて、それを24穴細胞培養プレートの底面と接触しないように配置し、小区画内に血管内皮細胞を飽和状に培養して、24穴細胞培養プレート内に癌細胞を共存培養することで生ずる血管内皮細胞の細胞間隔程度を一定最短距離で電極を挿むことを特徴とする抵抗測定器である。   In addition, the second invention is an invention of a resistance measuring instrument, and a polycarbonate filter and a polystyrene cylinder having pores which are chemotaxis chambers using an existing device designed for analyzing chemotaxis. Is placed so as not to contact the bottom of the 24-well cell culture plate, and vascular endothelial cells are saturated in the small compartment and placed in the 24-well cell culture plate. This is a resistance measuring instrument in which electrodes are inserted at a fixed shortest distance between vascular endothelial cells produced by co-culturing cancer cells.

この発明によると、先ず、第一の発明である即ち,請求項1記載の発明によれば、癌細胞と血管内皮細胞が直接接触することなく、即ち,非接触状態での共存培養することができ、癌細胞から分泌されると思われる血管内皮細胞の開裂現象に関与する成分を長時間的に供給することが可能となり、血管内皮細胞の開裂現象に注目することで癌転移モデルを構築し、転移能を評価することができる。   According to this invention, first, according to the first invention, that is, the invention according to claim 1, the cancer cells and the vascular endothelial cells are not directly contacted, that is, can be co-cultured in a non-contact state. It is possible to supply components involved in the vascular endothelial cell cleavage phenomenon, which are thought to be secreted from cancer cells, over a long period of time. By focusing on the vascular endothelial cell cleavage phenomenon, a cancer metastasis model was constructed. The metastatic ability can be evaluated.

また、第二の発明である,請求項2記載の発明のケモタキシスチャンバー中に培養した血管内皮細胞の開裂レベルを評価するために、培養内皮細胞の層を挿む形で最短距離で固定する電極を用いるので、内皮細胞の開裂レベルが高感度に測定できる等極めて有益なる効果を奏する。   In addition, in order to evaluate the cleavage level of vascular endothelial cells cultured in the chemotaxis chamber according to the invention of claim 2, which is the second invention, fixation is performed at the shortest distance by inserting a layer of cultured endothelial cells. Since the electrode to be used is used, there are extremely beneficial effects such that the cleavage level of the endothelial cells can be measured with high sensitivity.

以下、この発明の請求項1に記載された発明の実施をするための最良の形態について、説明すると、血管内皮細胞と癌細胞の非接触共培養系について説明する。   Hereinafter, the best mode for carrying out the invention described in claim 1 of the present invention will be described. A non-contact co-culture system of vascular endothelial cells and cancer cells will be described.

図1は、この発明の血管内皮細胞と癌細胞の非接触共培養系の一例を示し、この培養系は孔径0.4〜8マイクロメーターの細孔を有するポリカーボネイトフィルター(1)を取り付けたポリプロピレン製円筒型のケモタキシスチャンバー(2)をポリプロピレン製24穴培養プレート(3)と懸隔する。   FIG. 1 shows an example of a non-contact co-culture system of vascular endothelial cells and cancer cells according to the present invention. This culture system is a polypropylene to which a polycarbonate filter (1) having pores having a pore diameter of 0.4 to 8 micrometers is attached. The cylindrical chemotaxis chamber (2) is suspended from the polypropylene 24-well culture plate (3).

ポリカーボネイトフィルター(1)の細胞外マトリックス構成成分(4)をコーティングし、その上にヒト臍帯由来血管内皮細胞を常法に従い播種し、3〜5日後に、血管内皮細胞がチャンバー(2)内のフィルター(1)の一面に血管内皮細胞の層(5)が形成される。   The extracellular filter component (4) of the polycarbonate filter (1) is coated, on which human umbilical cord-derived vascular endothelial cells are seeded according to a conventional method, and after 3 to 5 days, the vascular endothelial cells are in the chamber (2). A layer (5) of vascular endothelial cells is formed on one side of the filter (1).

ポリカーボネイトフィルター(1)が透視可能なものであれば、細胞間隔程度を顕微鏡下で観察可能であるが、後に詳しく説明する培養コンパートメント上層部(7)と下層部(8)との間の電気抵抗レベルで判断出来る。目的に応じて上層部(7)及び下層部(8)の培地中に試料を加えて前培養するものである。   If the polycarbonate filter (1) can be seen through, the cell spacing can be observed under a microscope, but the electrical resistance between the culture compartment upper layer (7) and lower layer (8), which will be described in detail later. Can be judged by level. Depending on the purpose, the sample is added to the medium of the upper layer part (7) and the lower layer part (8) and pre-cultured.

前述したポリプロピレン製24穴培養プレート(3)の底に細胞株として確立された癌細胞や人体より分離された癌組織を培養した癌細胞(6)を播種する。目的に応じて培地中に試料を加えて前培養する。この発明に使用する癌細胞は特にその種類を限定しないが、癌細胞の種類によって、後述する電気抵抗を測定するタイミングは若干異なる。   On the bottom of the polypropylene 24-well culture plate (3) described above, cancer cells established as cell lines and cancer cells (6) obtained by culturing cancer tissues isolated from the human body are seeded. Depending on the purpose, a sample is added to the medium and precultured. The type of cancer cell used in the present invention is not particularly limited, but the timing of measuring the electrical resistance described later differs slightly depending on the type of cancer cell.

フィルター(1)の一面に血管内皮細胞の層(5)が形成されたケモタキシスチャンバー(2)を24穴培養プレート(3)のウエル中に培養し、培養液中に癌細胞(6)から内皮細胞を開裂する成分が分泌されている状態の培養プレートと併せ、一定時間培養することで、癌細胞が血管内皮細胞を開裂し周辺組織を浸潤、転移する過程の試験管外モデル化を構築するものである。   A chemotaxis chamber (2) having a vascular endothelial cell layer (5) formed on one side of the filter (1) is cultured in a well of a 24-well culture plate (3), and cancer cells (6) are contained in the culture solution. In vitro modeling of the process by which cancer cells cleave vascular endothelial cells, infiltrate the surrounding tissues, and metastasize by culturing for a certain period of time together with a culture plate in which components that cleave endothelial cells are secreted from To build.

以上のことから、この発明を実施するための最良の形態によれば、血管内皮細胞と癌細胞が直接接触することなく、共存培養することで癌細胞から分泌されると思われる血管内皮細胞の開裂に関与する成分を長時間供給することが可能となる。   From the above, according to the best mode for carrying out the present invention, vascular endothelial cells that are considered to be secreted from cancer cells by co-culturing without direct contact between vascular endothelial cells and cancer cells. It becomes possible to supply the components involved in the cleavage for a long time.

次に、第二の発明である癌転移抑制能測定器の最良の形態について説明すると、図2に示すように、24穴培養プレート(3)とウエルと同程度の抵抗測定コンパートメント容器(10)を別に用意し、血管内皮細胞(5)の開裂程度部分(9)を培養コンパートメントの上層部(7)と下層部(8)との間の電気抵抗レベルを測定するために、上層部(7)中に抵抗器(図示せず)の電極(11)を内皮細胞(5)と出来る限り接近させるように設置し、もう一方の電極(12)を容器(10)の底面に嵌め込む形状にする。上層部(7)に設置する電極(11)を測定時に用いる容器(10)の蓋(13)に固定することで、ケモタキシスチャンバー(2)の底面(1)との距離を抵抗測定の際に常に一定に出来るものである。尚、図3に示す(14)は、抵抗測定器EVOM(WPI社製)であり、(15)は、抵抗測定コンパートメントEndohm(WPI社製)である。   Next, the best mode of the cancer metastasis inhibitory capacity measuring apparatus according to the second invention will be described. As shown in FIG. 2, a 24-well culture plate (3) and a resistance measuring compartment container (10) similar to a well are used. In order to measure the electrical resistance level between the upper layer part (7) and the lower layer part (8) of the culture compartment, the upper part (7) is prepared. The electrode (11) of the resistor (not shown) is placed as close as possible to the endothelial cells (5), and the other electrode (12) is fitted into the bottom of the container (10). To do. By fixing the electrode (11) installed in the upper layer part (7) to the lid (13) of the container (10) used at the time of measurement, the distance from the bottom surface (1) of the chemotaxis chamber (2) can be measured. It can always be constant. In addition, (14) shown in FIG. 3 is a resistance measuring device EVOM (manufactured by WPI), and (15) is a resistance measuring compartment Endohm (manufactured by WPI).

以上のことから、本発明を実施するこめの最良の形態によれば、抵抗値という数値で血管内皮細胞の開裂程度を評価することで、顕微鏡下による細胞計測という測定者の個人的恣意の入り込む余地を少なくすることが可能となる。   From the above, according to the best mode for carrying out the present invention, the degree of cleavage of vascular endothelial cells is evaluated by a numerical value called resistance value, and the personal will of the measurer called cell measurement under a microscope is introduced. It is possible to reduce the room.

この発明は、癌転移抑制能を有する成分を検索し、転移抑制能を測定する方法および測定器の技術を確立することにより、産業上の利用可能性を有する。   The present invention has industrial applicability by searching for a component having cancer metastasis-inhibiting ability and establishing a technique and a measuring instrument for measuring metastasis-inhibiting ability.

この発明の一実施例を示す説明図である。It is explanatory drawing which shows one Example of this invention. この発明の他の実施例を示す説明図である。It is explanatory drawing which shows the other Example of this invention. この発明に使用する抵抗測定器の一実施例を示す説明図である。It is explanatory drawing which shows one Example of the resistance measuring device used for this invention. この発明の他の実施例を示す説明図である。It is explanatory drawing which shows the other Example of this invention. この発明による癌細胞および非癌細胞による内皮細胞の開裂程度を測定したグラフ図である。It is the graph which measured the cleavage degree of the endothelial cell by the cancer cell by this invention, and a non-cancer cell.

符号の説明Explanation of symbols

1 フィルター
2 ケモタキシスチャンバー
3 24穴培養プレート
4 細胞外マトリックス構成成分
5 血管内皮細胞
6 癌細胞
7 培養コンパートメント上層部
8 培養コンパートメント下層部
9 血管内皮細胞の開裂程度部分
10 抵抗測定コンパートメント容器
11 コンパートメント上層部電極
12 コンパートメント下層部電極
13 抵抗測定容器蓋
14 抵抗測定容器EVOM(WPI社)
15 抵抗測定コンパートメントEndohm(WP1社)
DESCRIPTION OF SYMBOLS 1 Filter 2 Chemotaxis chamber 3 24-well culture plate 4 Extracellular matrix component 5 Vascular endothelial cell 6 Cancer cell 7 Upper part of culture compartment 8 Lower part of culture compartment 9 Decomposition part of vascular endothelial cell 10 Resistance measurement compartment container 11 Compartment Upper layer electrode 12 Compartment lower layer electrode 13 Resistance measurement container lid 14 Resistance measurement container EVOM (WPI)
15 Resistance measurement compartment Endohm (WP1 company)

Claims (2)

抗転移剤の候補となる物質を、宿主側の内皮細胞の観点から選別することを目的として、血管内皮細胞と癌細胞を非接触共存培養することで生ずる、血管内皮細胞の細胞間隔程度を内皮細胞を横切る電気的抵抗量で評価することを特徴とする癌転移抑制能測定する方法。   For the purpose of selecting substances that are candidates for anti-metastatic agents from the viewpoint of host-side endothelial cells, the cell spacing of vascular endothelial cells produced by non-contact co-culture of vascular endothelial cells and cancer cells is determined to be endothelium. A method for measuring the ability to suppress cancer metastasis, characterized by evaluating the amount of electrical resistance across cells. 上部が開口し、底面に癌細胞を配置する24穴細胞培養プレートと、化学走性を解析するため開発され、底部に細孔を有するポリカーボネイトフィルターを設けたケモタキシスチャンバーと、前記24穴細胞培養プレートの底面が、ケモタキシスチャンバーと接触しないよう懸隔手段により懸隔し、小区画を形成し、該小区画内に血管内皮細胞を飽和状に培養し、前記24穴細胞培養プレート内に癌細胞を共存培養することで生ずる血管内皮細胞の細胞間隔程度を、前記ポリカーボネイトフィルターを介して一定最短距離で電極を挿むことを特徴とする癌転移抑制能測定器。   A 24-well cell culture plate having an opening at the top and cancer cells on the bottom, a chemotaxis chamber developed for analyzing chemotaxis and provided with a polycarbonate filter having pores at the bottom, and the 24-well cell The bottom surface of the culture plate is suspended by a suspension means so as not to contact the chemotaxis chamber, a small compartment is formed, vascular endothelial cells are saturated in the small compartment, and cancer is contained in the 24-well cell culture plate. A cancer metastasis inhibitory capacity measuring instrument, wherein an electrode is inserted at a certain shortest distance through the polycarbonate filter at a cell interval of vascular endothelial cells produced by co-culturing cells.
JP2004182162A 2004-06-21 2004-06-21 Method for measuring ability to inhibit cancer metastasis and measuring instrument therefor Active JP4587281B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004182162A JP4587281B2 (en) 2004-06-21 2004-06-21 Method for measuring ability to inhibit cancer metastasis and measuring instrument therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004182162A JP4587281B2 (en) 2004-06-21 2004-06-21 Method for measuring ability to inhibit cancer metastasis and measuring instrument therefor

Publications (2)

Publication Number Publication Date
JP2006003293A true JP2006003293A (en) 2006-01-05
JP4587281B2 JP4587281B2 (en) 2010-11-24

Family

ID=35771796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004182162A Active JP4587281B2 (en) 2004-06-21 2004-06-21 Method for measuring ability to inhibit cancer metastasis and measuring instrument therefor

Country Status (1)

Country Link
JP (1) JP4587281B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009027928A (en) * 2007-07-24 2009-02-12 Yasushi Tagawa Method for evaluating cancer metastasis ability and three-dimensional double membrane structure for evaluating cancer metastasis ability
EP2322925A3 (en) * 2009-11-12 2012-04-25 nanoAnalytics GmbH Device for determining the impedance of cell layers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05211893A (en) * 1992-01-31 1993-08-24 Agency Of Ind Science & Technol Apparatus for preparing vascular endothelial model and method for measuring metastatic ability of cancerous cell using the same
JPH06316543A (en) * 1993-03-10 1994-11-15 Morinaga Milk Ind Co Ltd Stilbene derivative and stilbene congener derivative and their use
JP2002518678A (en) * 1998-06-12 2002-06-25 セネス リミティド High throughput screen
WO2004010102A2 (en) * 2002-07-20 2004-01-29 Acea Biosciences, Inc. Impedance based apparatuses and methods for analyzing cells and particles
WO2004040312A2 (en) * 2002-10-28 2004-05-13 bioMérieux Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05211893A (en) * 1992-01-31 1993-08-24 Agency Of Ind Science & Technol Apparatus for preparing vascular endothelial model and method for measuring metastatic ability of cancerous cell using the same
JPH06316543A (en) * 1993-03-10 1994-11-15 Morinaga Milk Ind Co Ltd Stilbene derivative and stilbene congener derivative and their use
JP2002518678A (en) * 1998-06-12 2002-06-25 セネス リミティド High throughput screen
WO2004010102A2 (en) * 2002-07-20 2004-01-29 Acea Biosciences, Inc. Impedance based apparatuses and methods for analyzing cells and particles
WO2004040312A2 (en) * 2002-10-28 2004-05-13 bioMérieux Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009027928A (en) * 2007-07-24 2009-02-12 Yasushi Tagawa Method for evaluating cancer metastasis ability and three-dimensional double membrane structure for evaluating cancer metastasis ability
EP2322925A3 (en) * 2009-11-12 2012-04-25 nanoAnalytics GmbH Device for determining the impedance of cell layers

Also Published As

Publication number Publication date
JP4587281B2 (en) 2010-11-24

Similar Documents

Publication Publication Date Title
Tian et al. The nanomechanical signature of liver cancer tissues and its molecular origin
Vinci et al. Tumor spheroid-based migration assays for evaluation of therapeutic agents
Zhou et al. AFM nanoindentation detection of the elastic modulus of tongue squamous carcinoma cells with different metastatic potentials
Paul et al. Tissue architectural cues drive organ targeting of tumor cells in zebrafish
Eker et al. Label-free recognition of drug resistance via impedimetric screening of breast cancer cells
Malaquin et al. Assessing functional roles of the senescence-associated secretory phenotype (SASP)
Yamada et al. RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression
JP2021518744A (en) New devices and methods for detecting disease
Totti et al. A novel versatile animal-free 3D tool for rapid low-cost assessment of immunodiagnostic microneedles
Kim et al. Visco-node-pore sensing: A microfluidic rheology platform to characterize viscoelastic properties of epithelial cells
Pospelova et al. An integrated approach for monitoring cell senescence
Weitz et al. Functional assay of cancer cell invasion potential based on mechanotransduction of focused ultrasound
JP5330657B2 (en) Cancer metastasis evaluation method and three-dimensional double membrane structure for cancer metastasis evaluation
JP4587281B2 (en) Method for measuring ability to inhibit cancer metastasis and measuring instrument therefor
JP2012520446A5 (en)
JPWO2016013041A1 (en) Peripheral circulating cancer cell detection method and detection apparatus
JP5527573B2 (en) MCF7-derived cells
Rožanc et al. Methods for Analyzing the Biological and Biomedical Properties of Biomaterials
Engbers-Buijtenhuijs et al. Analysis of the balance between proliferation and apoptosis of cultured vascular smooth muscle cells for tissue-engineering applications
Karras et al. Patient-derived melanoma models
US20210247277A1 (en) Pretreatment Method for Fluorescent Image Diagnosis
Zhang et al. FAK-p38 signaling serves as a potential target for reverting matrix stiffness-modulated liver sinusoidal endothelial cell defenestration
Torab Collective Invasion In Heterogeneous Bladder Cancer Tumors: A Biomanufacturing Approach
Paquette et al. Loss of developmentally derived Irf8+ macrophages promotes hyperinnervation and arrhythmia in the adult zebrafish heart
Holland Towards non-invasive characterisation of re-endothelialisation and restenosis following coronary stenting: an in vitro investigation using impedance spectroscopy

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070613

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091023

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100803

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100902

R150 Certificate of patent or registration of utility model

Ref document number: 4587281

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130917

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250